These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 30489605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.
    Soliman W, Lund-Andersen H, Larsen M.
    Acta Ophthalmol Scand; 2006 Oct; 84(5):707-8. PubMed ID: 16965507
    [No Abstract] [Full Text] [Related]

  • 3. Volume Rendering of Optical Coherence Tomography Angiography Reveals Extensive Retinal Vascular Contributions to Neovascularization in Ocular Toxoplasmosis.
    Spaide RF.
    Retina; 2015 Nov; 35(11):2421-2. PubMed ID: 26405767
    [No Abstract] [Full Text] [Related]

  • 4. Rapid regression of retinal neovascularization following intravitreal bevacizumab in branch retinal vein occlusion imaged by optical coherence tomography angiography.
    Brar M, Grewal DS, Sharma M, Grewal SPS.
    Indian J Ophthalmol; 2018 Apr; 66(4):572. PubMed ID: 29582824
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2.
    Toygar O, Guess MG, Youssef DS, Miller DM.
    Retina; 2016 Nov; 36(11):2150-2157. PubMed ID: 27258671
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long term result of intravitreal bevacizumab in a patient newly transformed to proliferative macular telangiectasia type 2.
    Ozkaya A, Alkin Z, Karakucuk Y, Yazici AT, Demirok A.
    Middle East Afr J Ophthalmol; 2013 Nov; 20(4):360-2. PubMed ID: 24339691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Type 3 Neovascularization (Retinal-Choroidal Anastomosis) in Childhood Coats' Disease.
    Ramtohul P, Gascon P, Comet A.
    Ophthalmol Retina; 2019 Oct; 3(10):834. PubMed ID: 31585709
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pneumatic displacement and intravitreal bevacizumab in the management of subretinal haemorrhage caused by choroidal neovascularization.
    Hasler PW, la Cour M, Villumsen J.
    Acta Ophthalmol Scand; 2007 Aug; 85(5):577-9. PubMed ID: 17559558
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.